Podcast: Play in new window | Download
Subscribe: Google Podcasts | Spotify | RSS
Matt Kaeberlien is one of the leading researchers on the science of aging. I was beyond honored to have him on the show to discuss this now almost clieche question: “Is aging a disease?” Although the FDA and other health professionals don’t want to categorizes it as such, aging has many of the similarities of a disease.
This being the case we can, if willing, combat aging in a pro-active manner as though we were fighting a disease.
Matt is one of the leading experts in the burgeoning field of healthspan sciences. It’s not enough we are living longer. We must find ways to live healthier longer.
Matt has been at the forefront of research on Rapamycin, which while not a panacea has shown to be a powerful deterrent of some of the symptoms of aging. This was such a fascinating conversation, and I feel so lucky to have been able to share this time with Matt. I hope you enjoy the conversation as much as I did.
Dr. Kaeberlein’s research interests are focused on biological mechanisms of aging in order to facilitate translational interventions that promote healthspan and improve quality of life.
Academic and Medical Appointments
Professor, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, 2021-present
Adjunct Professor of Oral Health Sciences, University of Washington, Seattle, WA, 2016-present
Adjunct Professor of Genome Sciences, University of Washington, Seattle, WA, 2015-present
Professor, Department of Pathology, University of Washington, Seattle, WA, 2015-2020
Associate Professor, Department of Pathology, University of Washington, Seattle, WA, 2011-2015
Adjunct Associate Professor of Genome Sciences, University of Washington, Seattle, WA 2014-2015
Assistant Professor, Department of Pathology, University of Washington, Seattle, WA, 2006-2011
Education and Training
Postdoctoral Fellow, Department of Genome Sciences, University of Washington, Seattle, WA, 2003-2006
Massachusetts Institute of Technology, Cambridge, MA, Biology, Doctorate of Philosophy, 2002
Western Washington University, Seattle, WA, Bachelor of Science in Biochemistry, Bachelor of Arts in Mathematics, 1994-1997
The Dog Aging Project
About the Project
The goal of the Dog Aging Project is to understand how genes, lifestyle, and environment influence aging. We want to use that information to help pets and people increase healthspan, the period of life spent free from disease.
Follow me on insta @jasonwrightnow
Subscribe to the YouTube Channel HERE
2 thoughts on “Is Aging a Disease? Healthspan, Rapamycin, and The Dog Aging Project with Matt Kaeberlein, PhD”
What about an aging retina not regeneration of new cells
Actually a great question I’ve asked several guests. There have been significant breakthroughs pertaining to macular degeneration. From what experts have told me, they can’t completely regenerate the cells. However, they can now dramatically extend the life of existing cells. This is what most experts such as Dr. Kaeberlein, Joel Greene, Nayan Patel and others have shared with me. Focus needs to be on cell health for longevity.